Crispr Therapeutics shares owned by Spectrum Planning & Advisory Services
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Spectrum Planning & Advisory Services
from 13F filings
Historical chart of Spectrum Planning & Advisory Services investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Spectrum Planning & Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Spectrum Planning & Advisory Services
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $221k | 3.5k | 62.60 |
2023-06-30 | $207k | 3.7k | 56.25 |
2022-09-30 | $249k | 3.8k | 65.25 |
2022-06-30 | $238k | 3.9k | 60.85 |
2022-03-31 | $310k | 4.9k | 62.69 |
2021-12-31 | $375k | 4.9k | 75.83 |
2021-09-30 | $503k | 4.5k | 111.90 |
2021-06-30 | $740k | 4.6k | 161.85 |
2021-03-31 | $570k | 4.7k | 121.93 |
2020-12-31 | $700k | 4.6k | 153.01 |
More positions owned by Spectrum Planning & Advisory Services
View all positions for Spectrum Planning & Advisory Services